K

Kathrin U. Jansen

Pfizer (United States)

ORCID: 0000-0001-5354-4202

Publishes on Bacterial Infections and Vaccines, Cervical Cancer and HPV Research, Pneumonia and Respiratory Infections. 179 papers and 35.6k citations.

PubIndex Score98Top 2%How it's scored

179Publications

35.6kTotal Citations

First publication: 1982First senior author: 1995

Bacterial Infections and Vaccines Cervical Cancer and HPV Research Pneumonia and Respiratory Infections SARS-CoV-2 and COVID-19 Research Immunotherapy and Immune Responses

Top publicationsby citations

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, William C. Gruber, Uğur Şahin et al.|New England Journal of Medicine|2020

Cited by 15.7k

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Özlem Türeci, Alexander Muik et al.|Nature|2020

Cited by 2.1k

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kathrin U. Jansen, Kirsten E. Lyke et al.|Nature|2020

Cited by 1.6k

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Robert W. Frenck, William C. Gruber, Nicola P. Klein et al.|New England Journal of Medicine|2021

Cited by 937

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

Edward E. Walsh, William C. Gruber, Robert W. Frenck et al.|medRxiv|2020

Cited by 155